Meeting
2013 ASCO Annual Meeting
Molecular tumor profiling (MTP) of poorly differentiated neoplasms (PDN) of unknown primary site.
Authors
F Anthony Greco
Tennessee Oncology, PLLC/SCRI, Nashville, TN
F Anthony Greco , David R. Spigel , John D. Hainsworth
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Molecular Diagnostics and Imaging
Citation
J Clin Oncol 31, 2013 (suppl; abstr 11080)
DOI
10.1200/jco.2013.31.15_suppl.11080
Abstract #
11080
Poster Bd #
48C
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Rapid access to biomarker data in a community setting: Integration of next-generation sequencing into routine pathologic workflow.
First Author: Kirstin Perdrizet
Poster
2020 ASCO Virtual Scientific Program
A phase II, multicenter study of encorafenib/binimetinib followed by a rational triple-combination after progression in patients with advanced BRAF V600-mutated melanoma (LOGIC2).
First Author: Reinhard Dummer
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Observational analysis of IDO-1 expression in MEL samples assessed using an RNAscope assay.
First Author: Robert Charles Newton
Poster
2017 ASCO-SITC Clinical Immuno-Oncology Symposium
Diagnostic accuracy of molecular tumor profiling in determining the tissue of origin in adult patients with cancer of unknown primary: A meta-analysis.
First Author: Rowena Torres Inocencio